APA

Guberina M., Eberhardt W., Stuschke M., Gauler T., Heinzelmann F., Cheufou D., Kimmich M., Friedel G., Schmidberger H., Darwiche K., Jendrossek V., Schuler M., Stamatis G. & Pöttgen C. (20180302). Heart dose exposure as prognostic marker after radiotherapy for resectable stage IIIA/B non-small-cell lung cancer: secondary analysis of a randomized trial. : Annals of oncology : official journal of the European Society for Medical Oncology.

Chicago

Guberina M, Eberhardt W, Stuschke M, Gauler T, Heinzelmann F, Cheufou D, Kimmich M, Friedel G, Schmidberger H, Darwiche K, Jendrossek V, Schuler M, Stamatis G and Pöttgen C. 20180302. Heart dose exposure as prognostic marker after radiotherapy for resectable stage IIIA/B non-small-cell lung cancer: secondary analysis of a randomized trial. : Annals of oncology : official journal of the European Society for Medical Oncology.

Harvard

Guberina M., Eberhardt W., Stuschke M., Gauler T., Heinzelmann F., Cheufou D., Kimmich M., Friedel G., Schmidberger H., Darwiche K., Jendrossek V., Schuler M., Stamatis G. and Pöttgen C. (20180302). Heart dose exposure as prognostic marker after radiotherapy for resectable stage IIIA/B non-small-cell lung cancer: secondary analysis of a randomized trial. : Annals of oncology : official journal of the European Society for Medical Oncology.

MLA

Guberina M, Eberhardt W, Stuschke M, Gauler T, Heinzelmann F, Cheufou D, Kimmich M, Friedel G, Schmidberger H, Darwiche K, Jendrossek V, Schuler M, Stamatis G and Pöttgen C. Heart dose exposure as prognostic marker after radiotherapy for resectable stage IIIA/B non-small-cell lung cancer: secondary analysis of a randomized trial. : Annals of oncology : official journal of the European Society for Medical Oncology. 20180302.